WASHINGTON — The Pharmaceutical Research and Manufacturers of America (PhRMA) yesterday brought more than 60 researchers and scientists from its member companies to meet with congressional lawmakers. PhRMA said the participants discussed how Congress can help support development of new, innovative medicines for patients in need. “America’s biopharmaceutical researchers and scientists are on the frontlines
The updated “Prescription Medicines: Costs In Context” report from the Pharmaceutical Research and Manufacturers of America (PhRMA) gives both a surprising and not-so-suprising snapshot of the changing Rx marketplace and how the nation’s health system is adapting. More than 7,000 medications are in development worldwide, led by drugs for cancer (1,813), neurological disorders (1,329), infectious
ARLINGTON, Va. — The National Association of Chain Drug Stores and the Pharmaceutical Research and Manufacturers of America (PhRMA) co-authored a Health Affairs article on research finding that when prescription drugs are taken as directed by a physician, other medical costs are reduced for certain Medicaid beneficiaries. Titled “Increased Use Of Prescription Drugs Reduces Medical
WASHINGTON — John Castellani, president and chief executive officer of Pharmaceutical Research and Manufacturers of America (PhRMA), plans to retire next year. PhRMA said Thursday that Castellani’s retirement is slated to go into effect Jan. 1, 2016. “Representing the biopharmaceutical industry has been one of the most rewarding experiences of my career, and I am
